ABILIFY

Product NDC: 59148-007
11-digit product format: 591480007
Labeler code: 59148
Product ID: 59148-007_1b189d15-798d-4bed-a93d-a543ed7abd81
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ARIPIPRAZOLE
Dosage form: TABLET
Route: ORAL
Labeler: Otsuka America Pharmaceutical, Inc.
Application: NDA021436
Marketing category: NDA
Marketing start: 2002-11-15
Substance: ARIPIPRAZOLE
Active strength: 5 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021436-001	ABILIFY	ARIPIPRAZOLE	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15
N021436-002	ABILIFY	ARIPIPRAZOLE	15MG	TABLET / ORAL	AB	RLD	2002-11-15
N021436-003	ABILIFY	ARIPIPRAZOLE	20MG	TABLET / ORAL	AB	RLD	2002-11-15
N021436-004	ABILIFY	ARIPIPRAZOLE	30MG	TABLET / ORAL	AB	RLD	2002-11-15
N021436-005	ABILIFY	ARIPIPRAZOLE	5MG	TABLET / ORAL	AB	RLD	2002-11-15
N021436-006	ABILIFY	ARIPIPRAZOLE	2MG	TABLET / ORAL	AB	RLD	2002-11-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-product	TE code
N021436-001	AB
N021436-002	AB
N021436-003	AB
N021436-004	AB
N021436-005	AB
N021436-006	AB

Orange Book patents#

Current patent rows page 1 of 1 · 12 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Submission date
N021436-001	9125939	2026-07-28	U-1749	2015-10-07
N021436-001	8759350	2027-03-02	U-1529	2014-07-22
N021436-002	9125939	2026-07-28	U-1749	2015-10-07
N021436-002	8759350	2027-03-02	U-1529	2014-07-22
N021436-003	9125939	2026-07-28	U-1749	2015-10-07
N021436-003	8759350	2027-03-02	U-1529	2014-07-22
N021436-004	9125939	2026-07-28	U-1749	2015-10-07
N021436-004	8759350	2027-03-02	U-1529	2014-07-22
N021436-005	9125939	2026-07-28	U-1749	2015-10-07
N021436-005	8759350	2027-03-02	U-1529	2014-07-22
N021436-006	9125939	2026-07-28	U-1749	2015-10-07
N021436-006	8759350	2027-03-02	U-1529	2014-07-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N021436-001	ABILIFY	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-002	ABILIFY	15MG	TABLET / ORAL	AB	RLD	2002-11-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-003	ABILIFY	20MG	TABLET / ORAL	AB	RLD	2002-11-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-004	ABILIFY	30MG	TABLET / ORAL	AB	RLD	2002-11-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-005	ABILIFY	5MG	TABLET / ORAL	AB	RLD	2002-11-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-006	ABILIFY	2MG	TABLET / ORAL	AB	RLD	2002-11-15	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021436-001	ABILIFY	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-002	ABILIFY	15MG	TABLET / ORAL	AB	RLD	2002-11-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-003	ABILIFY	20MG	TABLET / ORAL	AB	RLD	2002-11-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-004	ABILIFY	30MG	TABLET / ORAL	AB	RLD	2002-11-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-005	ABILIFY	5MG	TABLET / ORAL	AB	RLD	2002-11-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-006	ABILIFY	2MG	TABLET / ORAL	AB	RLD	2002-11-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021436-001	ABILIFY	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-002	ABILIFY	15MG	TABLET / ORAL	AB	RLD	2002-11-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-003	ABILIFY	20MG	TABLET / ORAL	AB	RLD	2002-11-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-004	ABILIFY	30MG	TABLET / ORAL	AB	RLD	2002-11-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-005	ABILIFY	5MG	TABLET / ORAL	AB	RLD	2002-11-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-006	ABILIFY	2MG	TABLET / ORAL	AB	RLD	2002-11-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-001	ABILIFY	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-002	ABILIFY	15MG	TABLET / ORAL	AB	RLD	2002-11-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-003	ABILIFY	20MG	TABLET / ORAL	AB	RLD	2002-11-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-004	ABILIFY	30MG	TABLET / ORAL	AB	RLD	2002-11-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-005	ABILIFY	5MG	TABLET / ORAL	AB	RLD	2002-11-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-006	ABILIFY	2MG	TABLET / ORAL	AB	RLD	2002-11-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021436-001	ABILIFY	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-002	ABILIFY	15MG	TABLET / ORAL	AB	RLD	2002-11-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-003	ABILIFY	20MG	TABLET / ORAL	AB	RLD	2002-11-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-004	ABILIFY	30MG	TABLET / ORAL	AB	RLD	2002-11-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-005	ABILIFY	5MG	TABLET / ORAL	AB	RLD	2002-11-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-006	ABILIFY	2MG	TABLET / ORAL	AB	RLD	2002-11-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-001	ABILIFY	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-002	ABILIFY	15MG	TABLET / ORAL	AB	RLD	2002-11-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-003	ABILIFY	20MG	TABLET / ORAL	AB	RLD	2002-11-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-004	ABILIFY	30MG	TABLET / ORAL	AB	RLD	2002-11-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-005	ABILIFY	5MG	TABLET / ORAL	AB	RLD	2002-11-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-006	ABILIFY	2MG	TABLET / ORAL	AB	RLD	2002-11-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-001	ABILIFY	10MG	TABLET / ORAL	AB	RLD, RS	2002-11-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-002	ABILIFY	15MG	TABLET / ORAL	AB	RLD	2002-11-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-003	ABILIFY	20MG	TABLET / ORAL	AB	RLD	2002-11-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-004	ABILIFY	30MG	TABLET / ORAL	AB	RLD	2002-11-15	`b8a1b40f171c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N021436-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-004	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-005	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-006	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021436-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-005	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-006	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021436-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-005	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-006	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-005	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-006	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021436-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-005	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021436-006	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-005	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021436-006	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021436-004	AB	1	`b8a1b40f171c…`

Observed Orange Book patent history#

Patent history page 1 of 54 · 2,124 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N021436-001	9125939	2026-07-28	U-1749	2015-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-001	8759350	2027-03-02	U-1529	2014-07-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-002	9125939	2026-07-28	U-1749	2015-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-002	8759350	2027-03-02	U-1529	2014-07-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-003	9125939	2026-07-28	U-1749	2015-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-003	8759350	2027-03-02	U-1529	2014-07-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-004	9125939	2026-07-28	U-1749	2015-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-004	8759350	2027-03-02	U-1529	2014-07-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-005	9125939	2026-07-28	U-1749	2015-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-005	8759350	2027-03-02	U-1529	2014-07-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-006	9125939	2026-07-28	U-1749	2015-10-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N021436-006	8759350	2027-03-02	U-1529	2014-07-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N021436-001	9125939	2026-07-28	U-1749	2015-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-001	8759350	2027-03-02	U-1529	2014-07-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-002	9125939	2026-07-28	U-1749	2015-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-002	8759350	2027-03-02	U-1529	2014-07-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-003	9125939	2026-07-28	U-1749	2015-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-003	8759350	2027-03-02	U-1529	2014-07-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-004	9125939	2026-07-28	U-1749	2015-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-004	8759350	2027-03-02	U-1529	2014-07-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-005	9125939	2026-07-28	U-1749	2015-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-005	8759350	2027-03-02	U-1529	2014-07-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-006	9125939	2026-07-28	U-1749	2015-10-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021436-006	8759350	2027-03-02	U-1529	2014-07-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021436-001	9125939	2026-07-28	U-1749	2015-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-001	8759350	2027-03-02	U-1529	2014-07-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-002	9125939	2026-07-28	U-1749	2015-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-002	8759350	2027-03-02	U-1529	2014-07-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-003	9125939	2026-07-28	U-1749	2015-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-003	8759350	2027-03-02	U-1529	2014-07-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-004	9125939	2026-07-28	U-1749	2015-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-004	8759350	2027-03-02	U-1529	2014-07-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-005	9125939	2026-07-28	U-1749	2015-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-005	8759350	2027-03-02	U-1529	2014-07-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-006	9125939	2026-07-28	U-1749	2015-10-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021436-006	8759350	2027-03-02	U-1529	2014-07-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-001	9125939	2026-07-28	U-1749	2015-10-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-001	8759350	2027-03-02	U-1529	2014-07-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-002	9125939	2026-07-28	U-1749	2015-10-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021436-002	8759350	2027-03-02	U-1529	2014-07-22	`31067a03dcf5…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 2 · 54 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021436-001	ODE-80	2021-12-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021436-002	ODE-80	2021-12-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021436-003	ODE-80	2021-12-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021436-004	ODE-80	2021-12-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021436-005	ODE-80	2021-12-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021436-006	ODE-80	2021-12-12	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N021436-001	ODE-80	2021-12-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021436-002	ODE-80	2021-12-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021436-003	ODE-80	2021-12-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021436-004	ODE-80	2021-12-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021436-005	ODE-80	2021-12-12	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021436-006	ODE-80	2021-12-12	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021436-001	ODE-80	2021-12-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021436-002	ODE-80	2021-12-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021436-003	ODE-80	2021-12-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021436-004	ODE-80	2021-12-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021436-005	ODE-80	2021-12-12	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021436-006	ODE-80	2021-12-12	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021436-001	ODE-80	2021-12-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021436-002	ODE-80	2021-12-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021436-003	ODE-80	2021-12-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021436-004	ODE-80	2021-12-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021436-005	ODE-80	2021-12-12	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021436-006	ODE-80	2021-12-12	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021436-001	ODE-80	2021-12-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021436-002	ODE-80	2021-12-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021436-003	ODE-80	2021-12-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021436-004	ODE-80	2021-12-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021436-005	ODE-80	2021-12-12	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021436-006	ODE-80	2021-12-12	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021436-001	ODE-80	2021-12-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021436-002	ODE-80	2021-12-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021436-003	ODE-80	2021-12-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021436-004	ODE-80	2021-12-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021436-005	ODE-80	2021-12-12	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021436-006	ODE-80	2021-12-12	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021436-001	ODE-80	2021-12-12	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021436-002	ODE-80	2021-12-12	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021436-003	ODE-80	2021-12-12	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021436-004	ODE-80	2021-12-12	`3f01610625f2…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: ABILIFY
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ARIPIPRAZOLE	5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
82VFR53I78	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 12 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
349490	Internal RxNorm lookup
349545	Internal RxNorm lookup
349547	Internal RxNorm lookup
349553	Internal RxNorm lookup
352307	Internal RxNorm lookup
352308	Internal RxNorm lookup
352309	Internal RxNorm lookup
352310	Internal RxNorm lookup
402131	Internal RxNorm lookup
404602	Internal RxNorm lookup
602964	Internal RxNorm lookup
615172	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
c040bd1d-45b7-49f2-93ea-aed7220b30ac	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
915afeb5-0b22-42c0-86ea-77abf1c5fe15	Product name	1	20250307
51c1e9bf-32c5-4a7b-b010-f93a90af7b6e	Product name	1	20231010
34645f32-2ac4-41bf-9c61-8107e4764a26	Product name	1	20181210
f8ff9e17-cd6c-4547-98c3-f5db0d1fc25d	Product name	1	20180110
14eaf619-f285-4cd0-9f39-d9dd8f3d9c02	Product name	1	20170824
8223ef47-de85-24dd-a9c7-5a041d2634a2	Product name	9	20170223

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
59148-007-13	2021-08-04	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-007-35	2021-08-04	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-007-94	2021-08-04	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-007-13	2021-07-23	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-007-35	2021-07-23	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002
59148-007-94	2021-07-23	These highlights do not include all the information needed to use ABILIFY safely and effectively. See full prescribing information for ABILIFY. ABILIFY ® (aripiprazole) Tablets, for oral use Initial U.S. Approval: 2002

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
59148-007-13	ABILIFY	30 in 1 BOTTLE, PLASTIC	TABLET	30	73
59148-007-35	ABILIFY	100 in 1 BLISTER PACK	TABLET	100	73
59148-007-94	ABILIFY	7 in 1 BLISTER PACK	TABLET	7	73

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59148-007-13	EA - Each	59148-007	3c930b61-b018-474f-819d-a29725677292	1	2012-07-24
59148-007-35	EA - Each	59148-007	60fe6a8a-fac1-4ce7-98f8-391f3b7232f0	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ARIPIPRAZOLE	ACTIVE INGREDIENT	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
ARIPIPRAZOLE	ACTIVE MOIETY	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ABILIFY (ARIPIPRAZOLE) TABLET [BRYANT RANCH PREPACK]	1000
ARIPIPRAZOLE	ACTIVE INGREDIENT	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
ARIPIPRAZOLE	ACTIVE MOIETY	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
ACESULFAME POTASSIUM	INACTIVE INGREDIENT	23OV73Q5G9	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
ASPARTAME	INACTIVE INGREDIENT	Z0H242BBR1	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
CALCIUM SILICATE	INACTIVE INGREDIENT	S4255P4G5M	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
FRUCTOSE	INACTIVE INGREDIENT	6YSS42VSEV	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
LACTIC ACID, DL-	INACTIVE INGREDIENT	3B8D35Y7S4	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
PHENYLALANINE	INACTIVE INGREDIENT	47E5O17Y3R	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
SUCROSE	INACTIVE INGREDIENT	C151H8M554	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
SULFOBUTYLETHER .BETA.-CYCLODEXTRIN	INACTIVE INGREDIENT	2PP9364507	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
TARTARIC ACID	INACTIVE INGREDIENT	W4888I119H	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
WATER	INACTIVE INGREDIENT	059QF0KO0R	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	ABILIFY (ARIPIPRAZOLE) TABLET ABILIFY (ARIPIPRAZOLE) SOLUTION ABILIFY DISCMELT (ARIPIPRAZOLE) TABLET, ORALLY DISINTEGRATING ABILIFY (ARIPIPRAZOLE) INJECTION, SOLUTION [OTSUKA AMERICA PHARMACEUTICAL, INC.]	56
ARIPIPRAZOLE	ACTIVE INGREDIENT	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
ARIPIPRAZOLE	ACTIVE MOIETY	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ABILIFY (ARIPIPRAZOLE) TABLET [H.J. HARKINS COMPANY, INC.]	3
ARIPIPRAZOLE	ACTIVE INGREDIENT	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
ARIPIPRAZOLE	ACTIVE INGREDIENT	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
ARIPIPRAZOLE	ACTIVE INGREDIENT	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
ARIPIPRAZOLE	ACTIVE MOIETY	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
ARIPIPRAZOLE	ACTIVE MOIETY	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
ARIPIPRAZOLE	ACTIVE MOIETY	82VFR53I78	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ABILIFY (ARIPIPRAZOLE) TABLET [CARILION MATERIALS MANAGEMENT]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ABILIFY (ARIPIPRAZOLE) TABLET [STAT RX USA LLC]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ABILIFY (ARIPIPRAZOLE) TABLET [TYA PHARMACEUTICALS]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59148-007	ABILIFY (ARIPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.]	73	Current NDC, Legacy NDC, 3 package rows	20250201_c040bd1d-45b7-49f2-93ea-aed7220b30ac.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ABILIFY	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	c040bd1d-45b7-49f2-93ea-aed7220b30ac	2025-01-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021436 application number: NDA021436 ndc (product): 59148-007

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
82VFR53I78	ARIPIPRAZOLE	129722-12-9	ARIPIPRAZOLE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
352307	ABILIFY 10 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352308	ABILIFY 15 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
615172	ABILIFY 2 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352309	ABILIFY 20 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352310	ABILIFY 30 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
404602	ABILIFY 5 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349545	ARIPiprazole 10 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349490	ARIPiprazole 15 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
602964	ARIPiprazole 2 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349553	ARIPiprazole 20 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349547	ARIPiprazole 30 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
402131	ARIPiprazole 5 MG Oral Tablet	PSN	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352307	aripiprazole 10 MG Oral Tablet [Abilify]	SBD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352308	aripiprazole 15 MG Oral Tablet [Abilify]	SBD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
615172	aripiprazole 2 MG Oral Tablet [Abilify]	SBD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352309	aripiprazole 20 MG Oral Tablet [Abilify]	SBD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352310	aripiprazole 30 MG Oral Tablet [Abilify]	SBD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
404602	aripiprazole 5 MG Oral Tablet [Abilify]	SBD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349545	aripiprazole 10 MG Oral Tablet	SCD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349490	aripiprazole 15 MG Oral Tablet	SCD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
602964	aripiprazole 2 MG Oral Tablet	SCD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349553	aripiprazole 20 MG Oral Tablet	SCD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
349547	aripiprazole 30 MG Oral Tablet	SCD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
402131	aripiprazole 5 MG Oral Tablet	SCD	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352307	Abilify 10 MG Oral Tablet	SY	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352308	Abilify 15 MG Oral Tablet	SY	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
615172	Abilify 2 MG Oral Tablet	SY	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352309	Abilify 20 MG Oral Tablet	SY	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
352310	Abilify 30 MG Oral Tablet	SY	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
404602	Abilify 5 MG Oral Tablet	SY	c040bd1d-45b7-49f2-93ea-aed7220b30ac	73
404602	ABILIFY 5 MG Oral Tablet	PSN	bbc2b53b-b712-49eb-b2ce-766bcc448616	3
404602	ABILIFY 5 MG Oral Tablet	PSN	d8275c2d-f42d-4f32-aa9f-03a202c8e99f	3
402131	ARIPiprazole 5 MG Oral Tablet	PSN	d8275c2d-f42d-4f32-aa9f-03a202c8e99f	3
402131	ARIPiprazole 5 MG Oral Tablet	PSN	bbc2b53b-b712-49eb-b2ce-766bcc448616	3
404602	aripiprazole 5 MG Oral Tablet [Abilify]	SBD	bbc2b53b-b712-49eb-b2ce-766bcc448616	3
404602	aripiprazole 5 MG Oral Tablet [Abilify]	SBD	d8275c2d-f42d-4f32-aa9f-03a202c8e99f	3
402131	aripiprazole 5 MG Oral Tablet	SCD	d8275c2d-f42d-4f32-aa9f-03a202c8e99f	3
402131	aripiprazole 5 MG Oral Tablet	SCD	bbc2b53b-b712-49eb-b2ce-766bcc448616	3
404602	Abilify 5 MG Oral Tablet	SY	bbc2b53b-b712-49eb-b2ce-766bcc448616	3
404602	Abilify 5 MG Oral Tablet	SY	d8275c2d-f42d-4f32-aa9f-03a202c8e99f	3
615172	ABILIFY 2 MG Oral Tablet	PSN	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
404602	ABILIFY 5 MG Oral Tablet	PSN	634b6431-48ca-480c-a4d8-0ba022bbf0f4	2
404602	ABILIFY 5 MG Oral Tablet	PSN	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
602964	ARIPiprazole 2 MG Oral Tablet	PSN	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
402131	ARIPiprazole 5 MG Oral Tablet	PSN	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
402131	ARIPiprazole 5 MG Oral Tablet	PSN	634b6431-48ca-480c-a4d8-0ba022bbf0f4	2
615172	aripiprazole 2 MG Oral Tablet [Abilify]	SBD	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
404602	aripiprazole 5 MG Oral Tablet [Abilify]	SBD	634b6431-48ca-480c-a4d8-0ba022bbf0f4	2
404602	aripiprazole 5 MG Oral Tablet [Abilify]	SBD	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
602964	aripiprazole 2 MG Oral Tablet	SCD	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
402131	aripiprazole 5 MG Oral Tablet	SCD	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
402131	aripiprazole 5 MG Oral Tablet	SCD	634b6431-48ca-480c-a4d8-0ba022bbf0f4	2
615172	Abilify 2 MG Oral Tablet	SY	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2
404602	Abilify 5 MG Oral Tablet	SY	634b6431-48ca-480c-a4d8-0ba022bbf0f4	2
404602	Abilify 5 MG Oral Tablet	SY	16710a27-aa76-4dd7-92e8-7d3c7efe3e42	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
59148-007-13	59148000713	30 TABLET in 1 BOTTLE, PLASTIC (59148-007-13)	30 tablet	2002-11-15	0000-00-00	No	No	Current
59148-007-35	59148000735	100 TABLET in 1 BLISTER PACK (59148-007-35)	100 tablet	2002-11-15	0000-00-00	No	No	Current
59148-007-94	59148000794	7 TABLET in 1 BLISTER PACK (59148-007-94)	7 tablet	2002-11-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ABILIFY	Otsuka America Pharmaceutical, Inc.	2025-01-29	HUMAN PRESCRIPTION DRUG LABEL	73
ABILIFY	Bryant Ranch Prepack	2019-09-12	HUMAN PRESCRIPTION DRUG LABEL	1002
ABILIFY	Carilion Materials Management	2016-08-06	HUMAN PRESCRIPTION DRUG LABEL	3
ABILIFY	TYA Pharmaceuticals	2014-07-03	HUMAN PRESCRIPTION DRUG LABEL	2
ABILIFY	H.J. Harkins Company, Inc.	2012-01-16	HUMAN PRESCRIPTION DRUG LABEL	3
ABILIFY	STAT RX USA LLC	2011-02-07	HUMAN PRESCRIPTION DRUG LABEL	2